U.S. FDA Approves New Indication for Merck Animal Health’s Bravecto® (fluralaner topical solution) for Cats and Bravecto® Plus (fluralaner and moxidectin topical solution) for Cats
Single dose topical treatments are the first and only U.S. products to treat and control Asian longhorned (Haemaphysalis longicornis) ticks in felines MADISON, N.J., September 6, 2022 – Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced […]